Notice Information
Notice Title
CORRIGENDUM - The Procurement of Active Pharmaceutical Ingredient Physostigmine Free Base
Notice Description
The purpose of this Prior Information Notice (PIN) is to: * Share information on Dstl's current thinking regarding a requirement to supply a quantity of Physostigmine Free Base over the next 5-7 years, with the potential for a long term supply; * Obtain views & feedback on this from the market, including responses to the questions detailed in this document; * Provide the ability for the market to highlight areas of opportunity/innovation that Dstl are not currently aware of; * Use the feedback & information to inform & support the development of the future Business Case(s) & Procurement Strategy. This PIN questionnaire is not a request for a full proposal or bid nor should it be taken to be a call for competition, it is purely to obtain information from early engagement with the market. In supporting a potential wider MOD requirement, Dstl is currently exploring the availability & capacity within the market to supply a quantity of the Active Pharmaceutical Ingredient (API), Physostigmine Free Base (also known as eserine; chemical name 1,2,3,3ab,8,8ab-hexahydro-1,3a,8-trimethylpyrrolo[2,3-b] indol-5-yl-methylcarbamate; chemical formula C15H21N3O2; molecular weight 275,36 g/mol). Under consideration is the development, process validation, manufacture & supply of this API with an outline indicative quantity of approx.15kg to 20kg per annum. The PIN questionnaire is seeking to identify where possible that the ultimate requirement is market facing/realistic/deliverable & the potential cost of the approach. Any information shared in response to the questionnaire, will be provided on the basis that it gives Dstl/UK MOD with free & unrestricted use of it in consideration of our requirement. It will not be shared outside of Dstl/UK MOD. Dstl is also interested in responses that propose different approaches or areas of efficiency that subject matter experts consider could be deemed in scope. Dstl gives no guarantee whatsoever that such proposals will be taken forward.
Lot Information
Lot 1
Prior Information Notice (PIN) Questionnaire - Procurement of Active Pharmaceutical Ingredient - Physostigmine Free Base Purpose: The purpose of this Prior Information Notice (PIN) questionnaire is to: * Share information on Dstl's current thinking regarding a requirement to supply a quantity of Physostigmine Free Base over the next 5-7 years, with the potential for a long term supply; * Obtain views and feedback on this from the market, including responses to the questions detailed in this document; * Provide the ability for the market to highlight areas of opportunity/innovation that Dstl are not currently aware of; * Use the feedback and information to inform and support the development of the future Business Case(s) and Procurement Strategy. This PIN questionnaire is not a request for a full proposal or bid nor should it be taken to be a call for competition, it is purely to obtain information from early engagement with the market. Background: In supporting a potential wider MOD requirement, Dstl is currently exploring the availability and capacity within the market to supply a quantity of the Active Pharmaceutical Ingredient (API), Physostigmine Free Base (also known as eserine; chemical name 1,2,3,3ab,8,8ab-hexahydro-1,3a,8-trimethylpyrrolo[2,3-b] indol-5-yl-methylcarbamate; chemical formula C15H21N3O2; molecular weight 275,36 g/mol). Under consideration is the development, process validation, manufacture and supply of this API with an outline indicative quantity of approx. 15kg to 20kg per annum The Purpose of this PIN questionnaire is to assist in preparing a Business Case and Procurement Strategy for this future requirement. The PIN questionnaire is seeking feedback and advice from the market to help understand and to identify where possible that the ultimate requirement is market facing/realistic/deliverable and the potential cost of the approach; Please note that this is not a request for proposals or tenders at this stage. Any information shared with us in responses to the questionnaire, will be provided on the basis that it gives Dstl/UK MOD with the right to free and unrestricted use of it in consideration of our requirement. It will not, however, be shared outside of Dstl/UK MOD. Miscellaneous: Dstl is also interested in receiving responses that propose different approaches or areas of efficiency that subject matter experts in this field consider could be deemed to be in scope. Dstl gives no guarantee whatsoever that such proposals will be taken forward.
Notice Details
Publication & Lifecycle
- Open Contracting ID
- ocds-h6vhtk-033758
- Publication Source
- Find A Tender Service
- Latest Notice
- https://www.find-tender.service.gov.uk/Notice/030232-2022
- Current Stage
- Tender
- All Stages
- Planning, Tender
Procurement Classification
- Notice Type
- Planning Notice
- Procurement Type
- Standard
- Procurement Category
- Goods
- Procurement Method
- Not Specified
- Procurement Method Details
- Not specified
- Tender Suitability
- Not specified
- Awardee Scale
- Not specified
Common Procurement Vocabulary (CPV)
- CPV Divisions
33 - Medical equipments, pharmaceuticals and personal care products
-
- CPV Codes
33661700 - Other nervous system medicinal products
Notice Value(s)
- Tender Value
- Not specified
- Lots Value
- Not specified
- Awards Value
- Not specified
- Contracts Value
- Not specified
Notice Dates
- Publication Date
- 26 Oct 20223 years ago
- Submission Deadline
- Not specified
- Future Notice Date
- 29 Apr 2023Expired
- Award Date
- Not specified
- Contract Period
- Not specified - Not specified
- Recurrence
- Not specified
Notice Status
- Tender Status
- Planned
- Lots Status
- Planned
- Awards Status
- Not Specified
- Contracts Status
- Not Specified
Buyer & Supplier
Contracting Authority (Buyer)
- Main Buyer
- MINISTRY OF DEFENCE
- Contact Name
- ADP Procurement Team
- Contact Email
- adpprocurement@dstl.gov.uk
- Contact Phone
- Not specified
Buyer Location
- Locality
- SALISBURY
- Postcode
- SP4 0JQ
- Post Town
- Salisbury
- Country
- England
-
- Major Region (ITL 1)
- TLK South West (England)
- Basic Region (ITL 2)
- TLK7 Gloucestershire and Wiltshire
- Small Region (ITL 3)
- TLK72 Wiltshire
- Delivery Location
- Not specified
-
- Local Authority
- Wiltshire
- Electoral Ward
- Winterslow & Upper Bourne Valley
- Westminster Constituency
- Salisbury
Further Information
Open Contracting Data Standard (OCDS)
View full OCDS Record for this contracting process
The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.
{
"tag": [
"compiled"
],
"id": "ocds-h6vhtk-033758-2022-10-26T15:44:29+01:00",
"date": "2022-10-26T15:44:29+01:00",
"ocid": "ocds-h6vhtk-033758",
"description": "https://contracts.mod.uk/go/940803330180BD2BBCCE Closing date for responses to this PIN is 30 June 2022 23:59 GMT",
"initiationType": "tender",
"tender": {
"id": "Dstl/ADP/001-F01-PIN",
"legalBasis": {
"id": "32014L0024",
"scheme": "CELEX"
},
"title": "CORRIGENDUM - The Procurement of Active Pharmaceutical Ingredient Physostigmine Free Base",
"status": "planned",
"classification": {
"scheme": "CPV",
"id": "33661700",
"description": "Other nervous system medicinal products"
},
"mainProcurementCategory": "goods",
"description": "The purpose of this Prior Information Notice (PIN) is to: * Share information on Dstl's current thinking regarding a requirement to supply a quantity of Physostigmine Free Base over the next 5-7 years, with the potential for a long term supply; * Obtain views & feedback on this from the market, including responses to the questions detailed in this document; * Provide the ability for the market to highlight areas of opportunity/innovation that Dstl are not currently aware of; * Use the feedback & information to inform & support the development of the future Business Case(s) & Procurement Strategy. This PIN questionnaire is not a request for a full proposal or bid nor should it be taken to be a call for competition, it is purely to obtain information from early engagement with the market. In supporting a potential wider MOD requirement, Dstl is currently exploring the availability & capacity within the market to supply a quantity of the Active Pharmaceutical Ingredient (API), Physostigmine Free Base (also known as eserine; chemical name 1,2,3,3ab,8,8ab-hexahydro-1,3a,8-trimethylpyrrolo[2,3-b] indol-5-yl-methylcarbamate; chemical formula C15H21N3O2; molecular weight 275,36 g/mol). Under consideration is the development, process validation, manufacture & supply of this API with an outline indicative quantity of approx.15kg to 20kg per annum. The PIN questionnaire is seeking to identify where possible that the ultimate requirement is market facing/realistic/deliverable & the potential cost of the approach. Any information shared in response to the questionnaire, will be provided on the basis that it gives Dstl/UK MOD with free & unrestricted use of it in consideration of our requirement. It will not be shared outside of Dstl/UK MOD. Dstl is also interested in responses that propose different approaches or areas of efficiency that subject matter experts consider could be deemed in scope. Dstl gives no guarantee whatsoever that such proposals will be taken forward.",
"lots": [
{
"id": "1",
"description": "Prior Information Notice (PIN) Questionnaire - Procurement of Active Pharmaceutical Ingredient - Physostigmine Free Base Purpose: The purpose of this Prior Information Notice (PIN) questionnaire is to: * Share information on Dstl's current thinking regarding a requirement to supply a quantity of Physostigmine Free Base over the next 5-7 years, with the potential for a long term supply; * Obtain views and feedback on this from the market, including responses to the questions detailed in this document; * Provide the ability for the market to highlight areas of opportunity/innovation that Dstl are not currently aware of; * Use the feedback and information to inform and support the development of the future Business Case(s) and Procurement Strategy. This PIN questionnaire is not a request for a full proposal or bid nor should it be taken to be a call for competition, it is purely to obtain information from early engagement with the market. Background: In supporting a potential wider MOD requirement, Dstl is currently exploring the availability and capacity within the market to supply a quantity of the Active Pharmaceutical Ingredient (API), Physostigmine Free Base (also known as eserine; chemical name 1,2,3,3ab,8,8ab-hexahydro-1,3a,8-trimethylpyrrolo[2,3-b] indol-5-yl-methylcarbamate; chemical formula C15H21N3O2; molecular weight 275,36 g/mol). Under consideration is the development, process validation, manufacture and supply of this API with an outline indicative quantity of approx. 15kg to 20kg per annum The Purpose of this PIN questionnaire is to assist in preparing a Business Case and Procurement Strategy for this future requirement. The PIN questionnaire is seeking feedback and advice from the market to help understand and to identify where possible that the ultimate requirement is market facing/realistic/deliverable and the potential cost of the approach; Please note that this is not a request for proposals or tenders at this stage. Any information shared with us in responses to the questionnaire, will be provided on the basis that it gives Dstl/UK MOD with the right to free and unrestricted use of it in consideration of our requirement. It will not, however, be shared outside of Dstl/UK MOD. Miscellaneous: Dstl is also interested in receiving responses that propose different approaches or areas of efficiency that subject matter experts in this field consider could be deemed to be in scope. Dstl gives no guarantee whatsoever that such proposals will be taken forward.",
"status": "planned"
}
],
"items": [
{
"id": "1",
"additionalClassifications": [
{
"scheme": "CPV",
"id": "33661700",
"description": "Other nervous system medicinal products"
}
],
"deliveryAddresses": [
{
"region": "UK"
}
],
"relatedLot": "1"
}
],
"communication": {
"futureNoticeDate": "2023-04-30T00:00:00+01:00"
},
"coveredBy": [
"GPA"
],
"amendments": [
{
"id": "1",
"unstructuredChanges": [
{
"newValue": {
"text": "To receive a copy of the PIN Questionnaire, please send an email with your point of contact information to: ADPProcurement@dstl.gov.uk"
},
"where": {
"section": "VI.3",
"label": "Additional Information"
}
},
{
"newValue": {
"text": "To receive a copy of the PIN Questionnaire, please send an email with your point of contact information to: ADPProcurement@dstl.gov.uk"
},
"where": {
"section": "II.2.4",
"label": "Description of the Procurement"
}
}
],
"description": "Modification to the original information in the notice to provide interested economic operators with a process for obtaining the questionnaire relating to this PIN."
},
{
"id": "2",
"unstructuredChanges": [
{
"newValue": {
"text": "To receive a copy of the PIN Questionnaire, please send an email with your point of contact information to: ADPProcurement@dstl.gov.uk"
},
"where": {
"section": "VI.3",
"label": "Additional Information"
}
},
{
"newValue": {
"text": "To receive a copy of the PIN Questionnaire, please send an email with your point of contact information to: ADPProcurement@dstl.gov.uk"
},
"where": {
"section": "II.2.4",
"label": "Description of the Procurement"
}
},
{
"newValue": {
"classifications": [
{
"scheme": "CPV",
"id": "33690000",
"description": "Various medicinal products"
}
]
},
"where": {
"section": "II.2.2"
}
},
{
"newValue": {
"classifications": [
{
"scheme": "CPV",
"id": "73300000",
"description": "Design and execution of research and development"
}
]
},
"where": {
"section": "II.2.2"
}
},
{
"oldValue": {
"date": "2022-06-30T23:59:00+01:00"
},
"newValue": {
"date": "2022-11-30T23:59:00Z"
},
"where": {
"section": "VI.3"
}
}
],
"description": "Modification to the original information in the notice to provide interested economic operators with a process for obtaining the questionnaire relating to this PIN."
}
]
},
"parties": [
{
"id": "GB-FTS-52691",
"name": "Ministry of Defence",
"identifier": {
"legalName": "Ministry of Defence"
},
"address": {
"streetAddress": "Dstl, Porton Down",
"locality": "Salisbury",
"region": "UK",
"postalCode": "SP4 0JQ",
"countryName": "United Kingdom"
},
"contactPoint": {
"name": "ADP Procurement Team",
"email": "ADPProcurement@dstl.gov.uk"
},
"roles": [
"buyer"
],
"details": {
"url": "https://www.gov.uk/government/organisations/defence-science-and-technology-laboratory",
"classifications": [
{
"scheme": "TED_CA_TYPE",
"id": "MINISTRY",
"description": "Ministry or any other national or federal authority, including their regional or local subdivisions"
},
{
"scheme": "COFOG",
"id": "02",
"description": "Defence"
}
]
}
},
{
"id": "GB-FTS-66822",
"name": "Ministry of Defence",
"identifier": {
"legalName": "Ministry of Defence"
},
"address": {
"locality": "Salisbury Wiltshire",
"region": "UK",
"countryName": "United Kingdom"
},
"contactPoint": {
"email": "ADPProcurement@dstl.gov.uk"
},
"roles": [
"buyer"
],
"details": {
"url": "https://www.gov.uk/government/organisations/defence-science-and-technology-laboratory"
}
}
],
"buyer": {
"id": "GB-FTS-66822",
"name": "Ministry of Defence"
},
"language": "en"
}